Michela Del Prete

2.6k total citations
75 papers, 1.9k citations indexed

About

Michela Del Prete is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Michela Del Prete has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 21 papers in Epidemiology and 17 papers in Hepatology. Recurrent topics in Michela Del Prete's work include Neuroendocrine Tumor Research Advances (18 papers), Colorectal Cancer Treatments and Studies (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (16 papers). Michela Del Prete is often cited by papers focused on Neuroendocrine Tumor Research Advances (18 papers), Colorectal Cancer Treatments and Studies (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (16 papers). Michela Del Prete collaborates with scholars based in Italy, Canada and United States. Michela Del Prete's co-authors include Stefano Cascinu, Mario Scartozzi, Riccardo Giampieri, Luca Faloppi, Maristella Bianconi, Alessandro Bittoni, Jean‐Mathieu Beauregard, François-Alexandre Buteau, Antongiulio Faggiano and Elena Maccaroni and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michela Del Prete

72 papers receiving 1.9k citations

Peers

Countries citing papers authored by Michela Del Prete

Since Specialization

Citations

This map shows the geographic impact of Michela Del Prete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Del Prete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Del Prete more than expected).

Fields of papers citing papers by Michela Del Prete

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Del Prete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Del Prete. The network helps show where Michela Del Prete may publish in the future.

Co-authorship network of co-authors of Michela Del Prete

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Del Prete. A scholar is included among the top collaborators of Michela Del Prete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Del Prete. Michela Del Prete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes 2025 ·Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity ·Michela Del Prete, (unknown), Olga Disoteo, Federico Vignati, (unknown), (unknown)	2
2	Cognitive reserve moderates the relationship between sleep difficulties and executive functions in patients with Parkinson's disease 2023 ·Sleep Medicine ·Michela Del Prete, Nicola Cellini, Lucia Ronconi, Elisa Di Rosa	4
3	Real-Life Efficacy of Liraglutide Therapy on Weight-Loss in Patients with Overweight and Obesity 2023 ·Michela Del Prete, Federico Vignati, (unknown), (unknown), (unknown), (unknown)	1
4	Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy 2023 ·Cancers ·Riccardo Giampieri, (unknown), Alessandro Bittoni, Francesca Rastelli, Vincenzo Catalano, Michela Del Prete, Silvia Chiorrini, (unknown), Francesco Graziano, (unknown), Renato Bisonni, (unknown), Paolo Alessandroni, (unknown), Rossana Berardi	3
5	Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT 2018 ·EJNMMI Physics ·Michela Del Prete, Frédéric Arsenault, (unknown), (unknown), François-Alexandre Buteau, A. Ćeller, Jean‐Mathieu Beauregard	47
6	Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, (unknown), (unknown), Alexis Beaulieu, Jean‐Mathieu Beauregard	124
7	Optimal management of resected gastric cancer 2018 ·Cancer Management and Research ·Riccardo Giampieri, Michela Del Prete, Luca Cantini, (unknown), Alessandro Bittoni, Elena Maccaroni, Rossana Berardi	14
8	Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study 2017 ·European Journal of Nuclear Medicine and Molecular Imaging ·Michela Del Prete, François-Alexandre Buteau, Jean‐Mathieu Beauregard	86
9	Prognostic impact of CA15-3 pre-treatment levels in ovarian cancer patients 2017 ·Annals of Oncology ·Elena Maccaroni, Riccardo Giampieri, Michela Del Prete, (unknown), R. Bracci, (unknown), (unknown), Francesca Bianchi, Laura Belvederesi, (unknown), (unknown), Mirco Pistelli, Agnese Savini, (unknown), Z. Ballatore, Federica Bini, (unknown), Luca Cantini, (unknown), Rossana Berardi	1
10	Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 2017 ·Journal of Endocrinological Investigation ·Michela Del Prete, (unknown), Roberta Modica, Francesco Lassandro, Andrea Di Giorgio, Antônio C. Bianco, Matteo Muto, Maurizio Gasperi, (unknown), Annamaria Colao, Vincenzo Montesarchio, Antongiulio Faggiano	11
11	Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 2016 ·Scientific Reports ·Riccardo Giampieri, Lisa Salvatore, Michela Del Prete, Tiziana Prochilo, (unknown), Cristian Loretelli, Fotios Loupakis, Giuseppe Aprile, Elena Maccaroni, Kalliopi Andrikou, Maristella Bianconi, Alessandro Bittoni, Luca Faloppi, Laura Demurtas, Rodolfo Montironi, Marina Scarpelli, Alfredo Falcone, Alberto Zaniboni, Mario Scartozzi, Stefano Cascinu	22
12	The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 2016 ·Clinical Colorectal Cancer ·Riccardo Giampieri, Angelo Restivo, Valeria Pusceddu, Michela Del Prete, Elena Maccaroni, Alessandro Bittoni, Luca Faloppi, Kalliopi Andrikou, Maristella Bianconi, Francesco Cabras, Rossana Berardi, Luigi Zorcolo, Francesco Scintu, Stefano Cascinu, Mario Scartozzi	18
13	Prognostic role of the CDNK 1B V109G polymorphism in multiple endocrine neoplasia type 1 2015 ·Journal of Cellular and Molecular Medicine ·Luisa Circelli, Valeria Ramundo, Vincenzo Marotta, Concetta Sciammarella, Francesca Marciello, Michela Del Prete, Lina Sabatino, Daniela Pasquali, Francesco Izzo, Stefania Scala, Annamaria Colao, Antongiulio Faggiano, Vittorio Colantuoni, (unknown)	22
14	Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 2014 ·Endocrine ·Francesco Fiore, Michela Del Prete, Renato Franco, Vincenzo Marotta, Valeria Ramundo, Francesca Marciello, Antonella Di Sarno, Anna Chiara Carratù, (unknown), Annamaria Colao, Antongiulio Faggiano	88
15	Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 2014 ·Endocrine ·Francesca Marciello, Carolina Di Somma, Michela Del Prete, Vincenzo Marotta, Valeria Ramundo, (unknown), (unknown), Luigi Camera, Annamaria Colao, Antongiulio Faggiano	5
16	Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach 2013 ·PLoS ONE ·Alessandro Bittoni, Mario Scartozzi, Riccardo Giampieri, Luca Faloppi, Maristella Bianconi, Alessandra Mandolesi, Michela Del Prete, Mirco Pistelli, Luca Cecchini, Italo Bearzi, Stefano Cascinu	56
17	Targeted therapy with kinase inhibitors in aggressive endocrine tumors 2013 ·Expert Opinion on Pharmacotherapy ·Vincenzo Marotta, (unknown), Michela Del Prete, Maria Grazia Chiofalo, Valeria Ramundo, (unknown), Francesca Marciello, Luciano Pezzullo, (unknown), Mario Vitale, Annamaria Colao, Antongiulio Faggiano	15
18	Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients 2013 ·PLoS ONE ·Riccardo Giampieri, Mario Scartozzi, Cristian Loretelli, Francesco Piva, Alessandra Mandolesi, Giovanni Lezoche, Michela Del Prete, Alessandro Bittoni, Luca Faloppi, Maristella Bianconi, Luca Cecchini, Mario Guerrieri, Italo Bearzi, Stefano Cascinu	35
19	Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab 2012 ·Journal of Translational Medicine ·Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni, Alessandra Mandolesi, (unknown), Simona Alfonsi, Lucio Giustini, Cristian Loretelli, Luca Faloppi, Alessandro Bittoni, Maristella Bianconi, Michela Del Prete, Italo Bearzi, Stefano Cascinu	24
20	Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients 2012 ·PLoS ONE ·Mario Scartozzi, Cristian Loretelli, Gennaro Galizia, Alessandra Mandolesi, Mirco Pistelli, Alessandro Bittoni, Riccardo Giampieri, Luca Faloppi, Maristella Bianconi, Michela Del Prete, Francesca Bianchi, Laura Belvederesi, Italo Bearzi, Stefano Cascinu	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact